Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 26NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1Heart Diseases 1Diabetes Mellitus 1

Interventions

Cyclophosphamide 13Bevacizumab 9Interleukin-2 8aldesleukin 7Paclitaxel 7fludarabine phosphate 6fludarabine 6Radiotherapy 6Bortezomib 6Thalidomide 5Gemcitabine 5Filgrastim 5veliparib 4sargramostim 4Vincristine 4Trastuzumab 4Prednisone 4Leucovorin 4Doxorubicin 4Biopsy 4vandetanib 3tariquidar 3romidepsin 3pazopanib 3montanide ISA 51 3Topotecan 3Specimen Handling 3Sorafenib 3Sirolimus 3Oxaliplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Neoplasms × Educational Status × Clear all
NCT00441077 2017-07-02

Interventions to Educate An Underserved Population About Inherited Disease Risks

National Institutes of Health Clinical Center (CC)

Phase NA Completed
550 enrolled

Diabetes Mellitus, Heart Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡